Relationship Between Extraintestinal Manifestations of Crohn's Disease and Patient-Reported and Disease Activity Outcomes in Adalimumab-Treated Patients in the Care Trial

被引：0
|
作者：
Reinisch, Walter
Lofberg, Robert
Louis, Edouard
Yu, Andrew P.
McHale, Joshua
Beaulieu, Nicolas
Chao, Jingdong
Mulani, Parvez
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A204 / A205
页数：2
相关论文
共 50 条
  • [1] Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease in the Care Trial
    Louis, Edouard
    Lofberg, Robert
    Reinisch, Walter
    Kron, Martina
    Camez, Anne
    Robinson, Anne
    Pollack, Paul F.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A196 - A196
  • [2] Relationship Between Crohn's Disease Activity Index and Patient-Reported Outcomes for Crohn's Disease Patients in the United States
    Obando, Camilo
    Ding, Zhijie
    Izanec, James
    Sikirica, Mirko
    Lucas, James
    Kemp, Jessalyn
    Muser, Erik
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S445
  • [3] Subanalysis of Remission Rates By Duration of Disease in Adalimumab-Treated Patients with Crohn's Disease: the Care Trial
    Reinisch, Walter
    Lofberg, Robert
    Louis, Edouard
    Kron, Martina
    Camez, Anne
    Robinson, Anne
    Pollack, Paul F.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A523 - A524
  • [4] Adalimumab Therapy reduces the presence of Extraintestinal Manifestations In patients with Crohn's Disease The CARE Trial
    Louis, E.
    Lofberg, R.
    Reinisch, W.
    Kron, M.
    Camez, A.
    Robinson, A.
    Pollack, P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S42 - S42
  • [5] Adalimumab-treated Patients with Moderate to Severe Crohn's Disease Experienced Reductions in Extraintestinal Manifestations: Data from CHARM
    Schwartz, David
    Lofberg, Robert
    Pollack, Paul
    Chen, Naijun
    Mulani, Parvez
    Chao, Jingdong
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S465 - S465
  • [6] Improvements in Work Productivity and Quality of Life in Adalimumab-Treated Patients with Crohn's Disease: the Care Trial
    Louis, Edouard
    Lofberg, Robert
    Reinisch, Walter
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A179 - A179
  • [7] Impact of adalimumab (HUMIRA®) on patient-reported outcomes among patients with fistulizing Crohn's disease in the CHARM trial
    Colombel, A.
    Loftus, E.
    Feagan, B.
    Schwartz, D.
    Wu, E.
    Yu, A.
    Pollack, P.
    Chao, P.
    Lomax, K.
    Mulani, P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S12 - S12
  • [8] Impact of adalimumab (HUMIRA®) on patient-reported outcomes among patients with fistulizing crohn's disease in the CHARM trial
    Colombel, J. F.
    Loftus, E. V.
    Feagan, B. G.
    Schwartz, D. A.
    Wu, E. Q.
    Yu, A.
    Pollack, P. F.
    Chao, J.
    Mulani, P.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S457 - S457
  • [9] Impact of adalimumab maintenance therapy on patient-reported outcomes among patients with fistulising Crohn's disease in the charm trial
    Colombel, J. F.
    Loftus, E. V.
    Feagan, B. G.
    Schwartz, D. A.
    Wu, E. Q.
    Yu, A.
    Pollack, P. F.
    Chao, J.
    Mulani, P.
    [J]. GUT, 2008, 57 : A116 - A116
  • [10] Effectiveness of Adalimumab for the Treatment of Extraintestinal Manifestations of Crohn's Disease
    Barreiro, Manuel
    Lorenzo, Aurelio
    Seoane, Montserrat
    Dominguez-Munoz, Enrique
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S692 - S692
12345